RaySearch Laboratories AB (publ) (STO:RAY.B)

Market Cap	11.41B
Revenue (ttm)	1.27B
Net Income (ttm)	223.62M
Shares Out	36.28M
EPS (ttm)	6.61
PE Ratio	47.60
Forward PE	43.05
Dividend	3.00 (0.95%)
Ex-Dividend Date	May 23, 2025

Volume	678,192
Average Volume	121,605
Open	283.50
Previous Close	240.50
Day's Range	280.00 - 315.50
52-Week Range	122.60 - 315.50
Beta	1.09
RSI	75.71
Earnings Date	Apr 25, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2000
• Employees: 416
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: RAY.B

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.